1.Dopamine agonists in the treatment of hyperprolactinemia cycle and fertility disorders: comparison between lisuride and bromocriptine.
Journal of Korean Society of Endocrinology 1992;7(1):8-15
No abstract available.
Bromocriptine*
;
Dopamine Agonists*
;
Dopamine*
;
Fertility*
;
Hyperprolactinemia*
;
Lisuride*
2.Effects of Central Dopaminergic Receptor-Activation on the Cardiovascular System.
Seung Min KIM ; Young Kwan PARK ; Sung Soo LEE ; Chang Mann KO
Journal of the Korean Neurological Association 1992;10(3):308-315
The central dopaminergic receptor is believed to suppress the cardiovascular system So it may be involved in the blood pressure regulation But, it's action is still controversial. Furthermore, the mechanisms involved in the central dopaminergic receptor-induced blood pressure regulation is unclear. So, present study was performed in order to clarify the effects of central dopaminergic receptor and to investigate the mechamisms involved in it. Lisuride a D2-receptor agonist, and clonidine, a alpha2-receptor agonist, were administered into lateral ventricle in rat and the changes of blood pressure were compared The results were as follows; 1. Intracerebroventricular administration of lisuride amd clonidine from 0.3 ug to 10 ug elicited dose related decrease of blood pressure and heart rate. The potencies were similar in both drugs. 2. Centrally administered sulpiride, a D2-antagonist, blocked only the lisuride-induced hypotension while the clonidine induced hypotension was blocked only by centrally adrninistered tolazoline, a alpha2-antagonist. Intravenous administration of both antagonists elicited no or minimal attenuabon of agonists effects. 3. After desipramine pretreatment, which increases the norepinephrine concentration lisuride elicited somewhat further decrease of blood pressure than normal, while clonidine administration caused rather increase in blood pressure. 4. After chemical sympathectomy by 6-hydroxydopamine, lisuride administration still elicited strong suppression of blood pressure. From thses above results, it is concluded that central dopaminergic receptor activation decrease the blood pressure. Suppression of the norepinephrine release at the sympathetic nerve terminal is not related with central dopaminergic receptor induced hypotension.
Administration, Intravenous
;
Animals
;
Blood Pressure
;
Cardiovascular System*
;
Clonidine
;
Desipramine
;
Heart Rate
;
Hypotension
;
Lateral Ventricles
;
Lisuride
;
Norepinephrine
;
Oxidopamine
;
Rats
;
Sulpiride
;
Sympathectomy, Chemical
;
Tolazoline
3.Mechanism of decrease in heart rate by peripheral dopaminergic D2-receptors.
Jung Han YOON ; Chang Mann KO ; Young Soo AHN ; Keum Soo PARK ; Kyung Hoon CHOE ; Kyung Ja YOO ; Kyung Hwan KIM ; Sung Soon KIM ; Bum Koo CHO
Yonsei Medical Journal 1994;35(4):411-419
We performed this study in order to verify the heart rate decrease caused by the D2-receptor on cardiac sympathetic nerve endings and its relation to the concentration of norepinephrine in synaptic clefts. Sprague-Dawley rats were pithed and the heart rate was increased either by electrical stimulation of the cardiac accelerator nerve or by intravenous infusion of norepinephrine, tyramine, or isoproterenol. Increased heart rate by electrical stimulation of cardiac accelerator nerve was dose-dependently lowered by lisuride and its effect was blocked by pretreatment with sulpiride but not with yohimbine and SCH 23390. Also, the heart rate was decreased in a dose-dependent manner by clonidine and this effect was blocked by pretreatment with yohimbine, but not with sulpiride. For increased heart rate by infusion of norepinephrine, tyramine, or isoproterenol, the heart rate lowering effect of lisuride was more marked in the norepinephrine-and tyramine-infusion groups, in which the intrasynaptic concentration of norepinephrine was elevated, compared to the isoproterenol-infusion group, in which intrasynaptic concentration of norepinephrine was not elevated. In conclusion, there is a D2-receptor on the cardiac sympathetic nerve endings which decreases the heart rate and is different from the presynaptic alpha 2-receptor. Also, the heart rate lowering effect via stimulation of the D2-receptor by lisuride was more marked with increased concentration of norepinephrine in the synaptic cleft.
Animal
;
Female
;
Heart/innervation
;
Heart Rate/drug effects/*physiology
;
Lisuride/pharmacology
;
Male
;
Norepinephrine/metabolism
;
Rats
;
Receptors, Dopamine D2/*physiology
;
Support, Non-U.S. Gov't
;
Sympathetic Nervous System/metabolism
;
Synapses/metabolism
;
Yohimbine/pharmacology